Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Current Period Unaudited)

v3.22.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2022
Jun. 30, 2021
Current assets:    
Cash and cash equivalents $ 160,821 $ 199,091
Short-term available-for-sale investments 70,351 32,463
Accounts receivable, less allowance for doubtful accounts of $1,522 and $1,229, respectively 202,095 145,385
Inventories 128,283 116,748
Other current assets 31,558 16,919
Total current assets 593,108 510,606
Property and equipment, net 218,398 207,907
Right of use asset 63,450 73,834
Goodwill 827,618 843,067
Intangible assets, net 551,342 615,968
Other assets 45,976 11,575
Total assets 2,299,892 2,262,957
Current liabilities:    
Trade accounts payable 30,859 29,384
Salaries, wages and related accruals 55,642 51,294
Accrued expenses 19,998 15,282
Contract liabilities 23,107 18,995
Income taxes payable 9,788 5,336
Operating lease liabilities - current 11,864 11,602
Contingent consideration payable   4,000
Current portion of long-term debt obligations 12,500 12,500
Other current liabilities 3,080 3,891
Total current liabilities 166,838 152,284
Deferred income taxes 99,301 93,125
Long-term debt obligations 246,514 328,827
Long-term contingent consideration payable 4,800 25,400
Operating lease liabilities 56,348 67,625
Other long-term liabilities 12,769 24,462
Bio-Techne's Shareholders' equity:    
Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding 0 0
Common stock, par value $.01 per share; authorized 100,000,000; issued and outstanding 39,263,444 and 38,955,484, respectively 393 390
Additional paid-in capital 636,321 534,411
Retained earnings 1,132,807 1,085,461
Accumulated other comprehensive loss (55,145) (57,291)
Total Bio-Techne's shareholders' equity 1,714,376 1,562,971
Noncontrolling interest (1,054) 8,263
Total shareholders' equity 1,713,322 1,571,234
Total liabilities and shareholders' equity $ 2,299,892 $ 2,262,957